TGA's booklet for medicinal cannabis use in MS

[..............................]

Interesting  read....

 

 

https://www.tga.gov.au/sites/default/files/guidance-use-medicinal-cannabis-treatment-multiple-sclerosis-australia.pdf

 

 

Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis  in Australia

 

 

Version 1, December 2017

 

 

 

A set of guidance documents has been made available to assist doctors and their patients

 

who choose to prescribe medicinal cannabis in Australia under current access schemes. These

 

have been developed based on reviews of available evidence for the use of medicinal cannabis

in five different settings. Included is an overview addressing the evidence base for medicinal

 

cannabis therapy generally as well as specific documents relating to medicinal cannabis in the

treatment of palliative care, epilepsy, chemotherapy-induced nausea and vomiting (CINV),

multiple sclerosis (MS) and chronic pain.

This document reflects the evidence supporting the use of medicinal cannabis in treating

symptoms of MS, including pain, spasticity, bladder spasm, ataxia and tremor, adverse events,

quality of life and disability and the recommendations of the Multiple Sclerosis Working Group.